Ibex Investors LLC Red Hill Biopharma Ltd. Transaction History

Ibex Investors LLC

$40.5 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$1.65 - $3.12 $431,666 - $816,241	-261,616 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$2.31 - $5.85 $1.05 Million - $2.65 Million	-453,677 Reduced 63.43%	261,616 $675,000
Q3 2021 Nov 05, 2021	SELL	$4.55 - $10.36 $1.16 Million - $2.65 Million	-255,643 Reduced 26.33%	715,293 $3.28 Million
Q2 2021 Aug 05, 2021	SELL	$5.98 - $7.51 $7.45 Million - $9.36 Million	-1,245,857 Reduced 56.2%	970,936 $6.68 Million
Q1 2021 May 12, 2021	BUY	$6.98 - $11.29 $2.26 Million - $3.66 Million	324,200 Added 17.13%	2,216,793 $16.2 Million
Q4 2020 Feb 03, 2021	BUY	$7.81 - $10.39 $132,707 - $176,546	16,992 Added 0.91%	1,892,593 $15.3 Million
Q3 2020 Nov 03, 2020	BUY	$6.34 - $10.83 $35,510 - $60,658	5,601 Added 0.3%	1,875,601 $19.2 Million
Q2 2020 Aug 12, 2020	BUY	$4.6 - $8.6 $92,000 - $172,000	20,000 Added 1.08%	1,870,000 $12.5 Million
Q1 2020 May 14, 2020	BUY	$3.51 - $6.17 $339,083 - $596,052	96,605 Added 5.51%	1,850,000 $8.38 Million
Q4 2019 Feb 05, 2020	BUY	$5.76 - $7.35 $9.5 Million - $12.1 Million	1,649,722 Added 88.83%	3,506,790 $21.3 Million
Q4 2019 Feb 05, 2020	SELL	$5.76 - $7.35 $10.1 Million - $12.9 Million	-1,753,395 Reduced 50.0%	1,753,395 $10.6 Million
Q3 2019 Nov 01, 2019	SELL	$6.46 - $8.37 $64,160 - $83,130	-9,932 Reduced 0.53%	1,857,068 $13.1 Million
Q2 2019 Jul 29, 2019	BUY	$6.34 - $8.8 $5.65 Million - $7.84 Million	891,072 Added 91.31%	1,867,000 $12.1 Million
Q1 2019 May 07, 2019	BUY	$6.06 - $9.0 $223,698 - $332,226	36,914 Added 3.93%	975,928 $8.11 Million
Q4 2018 Feb 13, 2019	BUY	$5.18 - $9.35 $2.13 Million - $3.85 Million	412,014 Added 78.18%	939,014 $5.21 Million
Q3 2018 Nov 13, 2018	BUY	$6.0 - $11.35 $162,000 - $306,450	27,000 Added 5.4%	527,000 $4.65 Million
Q2 2018 Aug 14, 2018	BUY	$4.82 - $8.53 $236,180 - $417,969	49,000 Added 10.86%	500,000 $4.27 Million
Q1 2018 May 15, 2018	BUY	$4.96 - $6.84 $33,227 - $45,821	6,699 Added 1.51%	451,000 $2.32 Million
Q4 2017 Feb 14, 2018	BUY	$4.58 - $10.81 $2.03 Million - $4.8 Million	444,301	444,301 $2.28 Million

Others Institutions Holding RDHL

# of Institutions

Shares Held

40.4K

Call Options Held

Put Options Held

Eaton Vance Management Boston, MA

40.4K
Shares

$282,919
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About RedHill Biopharma Ltd.

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $447M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

More about RDHL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibex Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ibex Investors LLC with notifications on news.

Account